chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician and medical records concerning a 3 day old male patient who on 05-OCT-2010 was vaccinated with the first dose of RECOMBIVAX HB (lot number not provided). Secondary suspect therapy given on 23-DEC-2010 included the first dose of ROTATEQ (manufacturer unknown) and the second dose of ROTATEQ (manufacturer unknown) given on 12-DEC-2011. Concomitant vaccination included the first dose of PENTACEL and the first dose of PCV-13 given on 12-DEC-2010 and the second dose of PENTACEL and PCV-13 given on 12-FEB-2011. It was reported that on 08-OCT-2010 laboratory tests were performed which included: white blood cell count: 8.4; mean corpuscular volume (MCV): 102.5; mean corpuscular hemoglobin concentration (NCHC): 35.4; red cell distribution width test (RDW): 17.0; reticulocyte count: 3.4. On 08-OCT-2010 mild jaundice was noted and body temperature was 98.5. A bilirubin test was performed: 15.7, 16.5. On 09-OCT-2010 the mother was advised to continue breast feeding. The patient was seen by the doctor 2 or 3 days later. On 11-OCT-2010 the patient still experienced jaundice. breastfeeding was good. On 20-OCT-2010 the patient presented yellow stools, it was also reported that the patient was spitting up a lot. The patient was switched to amino acids (unspecified) (+) arachidonic acid (+) carbohydrates (unspecified) (+) docosahexaenoic acid (+) fat (unspecified) (+) linoleic acid (+) minerals (unspecified) (+) protein (unspecified) (+) vitamins (unspecified) GENTLEAZE 4 ounces each 2-3 hours and seemed better. On 18-FEB-2011 the patient presented papular rash on arms and back and body temperature of 98.1. The patient also presented with atopic dermatitis. On 12-MAR-2011 the patient complained of cough and stuffy nose, the patient was treated with nasal saline. At the time of the report the patient's outcome was unknown. No further information is available.
Pt recvd 1st dose of Hep B vax w/no noted problem; Pt recvd 2nd dose of vax on 18AUG92 & w/in an hr following vax, pt exp sore arm w/pain @ the inject site; sx resolved w/in 24 hrs; No further details were provided;
Elevated temp of 104.5, local (lt upper arm) rxn; rash other than @ inject site; arm site swelling 2X normal size; vomiting approx 6X;
Rash (2 inches wide by 3.5 inches long) appeared on my left arm around the site of injection, 9 days after the injection.  The rash was red,  warm and a little itchy.  The redness increased for the folowing two days, creating a darker ring on the outer edge.  On the third day (12 days after injection) the redness started to lighten.  After four days, there is slight redness and warmth, but no itch.
Purpuric Rash, followed by thrombocytopenia and acute decline in GFR, hypertension.
Tinnitus of both ears. started very mild and has progressed to very load ringing in both ears. No signs of it changing
Increased tinnitus in left ear.  Noticeable new tinnitus in right ear.
Patient presented to ED after ground-level fall. Patient appears to have not lost consciousness or pulses. PT/OT attributed fall to generalized weakness and ambulation due to chronic deconditioning. Patient to follow up with neurology for further management of severe dementia. Per the EUA, hospitalizations are to be reported irrespective of attribution to the vaccine
Severe skin itching started 1/26/2022. Symetrical full body rash started 2/1/22, red target lesions. Swollen hands, feet and thighs, redness started 2/3/22. Seen at walkin 2/4/22, diagnosed with urticaria started on prednisone.  Throat thickness. Difficulty walking from severe foot pain. Severe hand pain and knee pain. Extreme fatigue.  Itchy eyes.  Blister lesions right wrist.  Seen again by PCP on 2/10/22 diagnosed with erythema multiforme.
Developed large, red, warm, bump on arm where inject took place.  Arm is painful, but red area has not progressed to any other part of the body.  Patient has had symptoms for 8 days and still currently has symptoms.
Pelvic pain; Pain travelled to her shoulders, outside her shoulders, and her neck; Pain in her neck; Pain in both of her knees Pain travelled to her shoulders, outside her shoulders; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PELVIC PAIN (Pelvic pain), PAIN (Pain travelled to her shoulders, outside her shoulders, and her neck), NECK PAIN (Pain in her neck) and ARTHRALGIA (Pain in both of her knees Pain travelled to her shoulders, outside her shoulders) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Arthritis of neck (She has previous diagnoses of arthritis in her neck) and Musculoskeletal stiffness (she was stiff as a board). Concurrent medical conditions included Movements reduced (she could not move) and Joint inflammation (her joints were inflamed).   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PELVIC PAIN (Pelvic pain), PAIN (Pain travelled to her shoulders, outside her shoulders, and her neck), NECK PAIN (Pain in her neck) and ARTHRALGIA (Pain in both of her knees Pain travelled to her shoulders, outside her shoulders). The patient was treated with PREDNISONE on 14-Jun-2021 for Joint pain, at an unspecified dose and frequency. At the time of the report, PELVIC PAIN (Pelvic pain), PAIN (Pain travelled to her shoulders, outside her shoulders, and her neck), NECK PAIN (Pain in her neck) and ARTHRALGIA (Pain in both of her knees Pain travelled to her shoulders, outside her shoulders) was resolving.            No concomitant medications were reported.
Sever muscle spasms the night after vaccination. Continued muscle spasms in the abdominal area.
Extreme muscle cramp in right calf; Extremely painful muscle; Can barely walk with it.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 04Apr2021 at 10:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN) for unknown indications from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on an unknown date Mar2021 at 10:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 11:00, the patient experienced extreme muscle cramp in right calf, first it was felt like a pop then it had been extremely painful and could barely walk with it. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme muscle cramp in right calf and extremely painful muscle and could barely walk was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a healthcare worker concerning a 19 year old female with no pertinent medical history who on 25-APR-1996 was vaccinated with VARIVAX (Merck). Concomitant therapy included hormonal contraceptives (unspecified). The patient experienced VZV antibody titer was negative. The patient's VZV antibody titer negative persisted. No further information is available.
Hospitalization: 4/23/2023 - 4/25/2023 (2 days) Presentation to the ED: syncopal episode COVID + date: 4/23/2023 Treatment: none.  Discharge to: home.
Ten days after vaccination, I developed sudden symptoms of insomnia, chest tightness, shortness of breath, and extreme fatigue. These improved somewhat over the following two months at which time I took my second vaccine and had a massive relapse with the same symptoms. Now, 6 months out, I am still dealing with life-altering extreme fatigue, insomnia, breathing abnormalities, and heart rate abnormalities.
Pt received Engerix series of 3 vaxs, & is a non responder
realized in between my 2nd dose and booster I had a spot appear in my vision; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Jun2021 at 15:00 as dose 2, single (Lot number: Ew0173) at the age of 29 years, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: Ew0185, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 18May2021, when the patient was 29-year-old, for COVID-19 immunization. The following information was reported: VISUAL IMPAIRMENT (non-serious), 1 day after the suspect product(s) administration, outcome "unknown", described as "realized in between my 2nd dose and booster I had a spot appear in my vision".  Additional information: Within a couple days of my booster I realized my vision was blurry. I couldn't see my tv and driving became extremely difficult. I also then realized in between my 2nd dose and booster I had a spot appear in my vision that remained for 2 weeks. My vision since my booster has not returned to normal and is still constantly blurry. The patient not had Covid tested prior vaccination and had Covid tested post vaccination.  No follow-up attempts possible. No further information expected.
1 day p/vax pt devel a 4inch by 4 inch area of redness & swelling @ the site of acel-immune administration;pt recovered w/o tx;this is 1 of 4 pt from this site to devel an inj site rxn p/vax;
Adverse effect of other vaccines and biological substances, initial encounter on 2022-01-05, Radiculopathy, cervical region on 2022-01-09.
Last night child ran a fever 103 was taking APAP this AM c/o of nausea, sore throat-throat was swollen as per mom.
Asymptomatic breakthrough COVID infection. Tested part of routine screening on admission. Positive swab collected 08/14/2022.
Numbness tingling (4-5x's); severe pain - feels like she was punched in back of arm and side. She can't even lift a glass of water. Pain radiated past elbow into forearm. She was cold all night and she's never cold. Pain feels 10x's worse than tetanus shot. Seeking tx from primary PCP at 1 PM today, 8-17-15.
Completely exhausted for 2 weeks; 3rd week off/on exhaustion. Then started noticing shortness of breath upon activity. Thought I was out of shape but it slowly became worse and worse. I then began wheezing upon minimal activity (carrying in groceries, playing with kids; walking up slight incline; couldn't finish very slow 1 mile walk). Could not catch a full breath for several months. That subsided, but still could not do anything without getting short of breath.
On 10/22/2022, I woke up with a sore throat which lasted all day. On 10/23/2022, in the evening and into the next day, I experienced sneezing and sniffles with a mild headache. I took an at home COVID-19 test on 10/23/2022 and it was negative. On 10/24/2022, my symptoms persisted and got worse, I also had nausea and diarrhea. On 10/25/2022, the symptoms continued with more head cold like symptoms. That night, I was feeling off and not quite normal. On 10/26/2022, I tested myself again in the morning for COVID-19 and it was positive. I notified my physician, who called in a prescription for Paxlovid. My symptoms continued along with a mild dry cough. On 10/27/2022, my symptoms continued, and I also noticed that I had lost my sense of taste and smell. After around mid-day, I felt some relief in some of my symptoms but still felt off. On Thursday, I had a mild fever with sweating, but some lessening of the head cold symptoms with the exception of the headache. Friday, I spent most of the day in bed, and I had been experiencing fatigue this entire time. Saturday, I was still tired and running a fever on and off with a headache and my head cold symptoms were getting better. This morning, I am still experiencing fatigue and some minor fever. I'm still feeling a tinge of pain in the right side of my head. I finished my last dose of Paxlovid yesterday. As of yesterday, I'm experiencing an occasional cough with phlegm.
Information has been received an office manager concerning 3 day old newborn female who on 03-SEP-2010 was inadvertently vaccinated with VAQTA (lot # not reported) instead of hepatitis B virus vaccine due to staff error. No adverse effects reported. The patient sought unspecified medical attention. Additional information has been requested.
on 08/31/2022 FDA AUTHORIZED NEW BIVALENT COVID VACCINE THEREFORE MONOVALENT IS NO LONGER AUTHORIZED AS BOOSTER . PT RECEIVED THE 4TH DOSE AS ERROR
Right area that itched around injection site. was 4x areas most of upper arm got pink, indurated and itched.
Reports that a few hours after receiving rabies vaccine her face and ears turned red and a rash appeared on her arms and legs. She reports feeling very anxious when this 1st appeared. Reports rash and red face lasted 2-3 days. Pt had recently began several new medicines which she stopped taking after the symptoms occurred. Legs swollen & had hives, painful if bent knees.
01/24/22 presents to ED for "Motor Vehicle Crash". PMHx of "asthma, GERD"
HE TESTED + FOR COVID AND WAS ADMITTED ON 6-5-22 TO  HOSPITAL  AND DISCHARGED 6-10-22 .  dIED AT HIS RESIDENCE 8-26-22.   HE CAME TO ER BY EMS WITH SIGNIFICANT SHORTNESS OF BREATH , HYPOXIA AND FELT SICK FOR 3-4 DAYS.  COUGH, CHEST CONGESTION AND LOW PULSE OX AT HOME AT 74 %.  WEAKNESS.  HIGH FEVER AT HOME.   PATIENT DECLINED LIFE SUPPORT/INTUBATION.  ON CPAP BY EMS AND SAT BETTER. CXR BILATERAL INFILTRATES.  HYPERCAPNIA ON ABG AND HYPOXIA , GIVEN DECADRON, FOUR DAYS OF REMDESIVIR.
EMPLOYEE REPORTS HEADACHE 3 HOURS AFTER VACCINATION. CHILLS, NAUSEA, BODY ACHES "LATER THAT NIGHT."  TYLENOL 800MG WAS TAKEN 1130PM 07/08/2021 AND TYLENOL 800MG 5AM 07/09/2021. SYMPTOMS ARE STILL PRESENT AT THIS TIME. EMPLOYEE WILL REPORTEDLY GO TO URGENT CARE TO BE SEEN THIS MORNING.
Information has been received from a licensed practical nurse (LPN) concerning a 6 months old patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies or concurrent conditions were not reported. On 30-NOV-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ administered orally for prophylaxis (lot number M019708 with an expiration date of 25-OCT-2017) (dose was not reported). Other suspect and concomitant medications were not provided. There was no adverse effect reported. The temperature excursion reported was 1 degree Celsius (C) for 48 hours. A digital data logger was involved. There were no previous temperature excursions. This is one of several reports received from the same reporter. Additional information is not expected as all follow up information has been received. Sender's Comments: US-009507513-1610USA013756.
PT TOOK CARE OF HUSBAND HAVING REACTIONS TO VACCINES DEALING WITH EMT AND THRE ER. WHEN SHE GOT HOME AT MIDNIGHT, SHE STARTED HAVING THE SHAKES AND CHILLS THAT LASTED HALF HOUR.
Patient is an 83 year old male admitted with COVID respiratory failure who  has end stage COPD. His condition declined throughout hospitalization and expired 7/2/2021.
syncope attack 2min post vax;BP 100/60, P80, skin cold & clammy pulse-ammonia inhalant, orange juice, observed for 30min;f/u w/PMD:
Got the vaccine, she went home around 3:30, and was very tired.  She woke up after 6:00 PM.  This morning she had swelling in her arms, real bumpy about 2 1/2" in diameter, looks like rocks, red/pink area 1 1/2".  It is very painful throbbing area on her arms,  getting worse.   She has been taking Tylenol.  She felt a little relief of the pain with the Tylenol.  She rested all day yesterday.  She left at 10:00 for her bridge club and that's where she noticed the reaction and has gotten home around 3:00 and not feeling well.  They told her to call us as they did not have any side effects from the vaccine.   She does have an appointment on 3/11/21 with her PCP.
A physician reported that an infant received Prevnar and subsequently, developed urticaria. At the date of this report, no further information was available.
Death.  I actually not sure which Covid Vaccine she took. I just know the date and time she took it at her local school where she worked. Died in her sleep after complaining of a headache. I talked to her around 5pm on sunday through a videochat and she seemed happy and well. But a local friend commented that she had complained of a headache late in the afternoon.
I got the vaccine on July 23rd in my left arm. On July 24th my left leg started burning, 3 days later I broke out with red welts on my back, chest, arms & legs. I have been to 7 specialist - 4 out of the 7 said it was a reaction to the vaccine. The next week after I got the vaccine, I went back to pharmacy to show the person "who gave me the vaccine" the welts on my back. He told me he didn't want to see the welts, and my reaction is not from the vaccine. I am still suffering from what I believe is a reaction from the shingles vaccine. I have been to 22 doctor appointments in the past 5 mos. If you can help me with any advice, I would appreciate it! Thank  you.
patient  was feeling under the weather over the weekend.  patient had body aches and headaches and her right arm was sore and swollen and a rash developed and was really hot.  pt went to urgent care and pt was told it was cellulitis and was given an antibiotics.
ELEVATED D-DIMER; SHORTNESS OF BREATH; HEADACHE; CHEST PAINS; DECREASED APPETITE; FEVER; This spontaneous report received from a physician concerned a 25 year old female. The patient's height, weight and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration, dose and batch number were not reported) administered on 07-APR-2021 for prophylactic vaccination. Batch number will be requested via follow up. Concomitant medications included unspecified oral contraceptives.  On 08-APR-2021, the subject experienced shortness of breath, headache, chest pains, fever, and decreased appetite.  Physician  saw the patient on 14-APR-2021 and ordered D-dimer which came back at "0.80" and again on 20-APR-2021 which came back "0.82" (units and normal range unspecified). Physician reported that the patient's platelet count had not been done yet, but the d-dimer was a little elevated and given her chest pains, he wanted to evaluate for a blood clot and possibly order CT (computed tomography) scan of her chest    The physician did mention VAERS report filed case # 446427.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, shortness of breath, and chest pains, and the outcome of decreased appetite, fever, and elevated d-dimer was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This case concerns a 25-year-old female who had elevated d-dimer test results 7 days after receiving the Janssen Covid-19 vaccine. Full medical history was not provided. Concomitant medications included unspecified oral contraceptives. The day after vaccination, the patient experienced shortness of breath, headache, chest pains, fever and decreased appetite.  Seven days post-vaccination, she went to see her physician who ordered a d-dimer test which came back elevated at 0.80 (normal range not reported). Repeat d-dimer test 6 days later came back at 0.82. A platelet level had not been checked, nor other diagnostic tests to evaluate for possible thrombosis. As of the the time of this report, the outcome was unknown.  Based on the available information, the relationship with Janssen Covid-19 vaccine is considered unclassifiable. Further information (e.g. full medical history, social history, family history, CBC, doppler ultrasound, anti-platelet factor 4 antibodies, fibrinogen) will be requested.
Headache; Achy/ achiness from the neck down to the feet; Soreness; Fatigue; sore throat; just basically I can barely move; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 28Apr2021 (Lot number was not reported) as SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included received first dose of BNT162B2 via an unspecified route of administration on an unspecified date as SINGLE for covid-19 immunization. It was reported that the patient had the second dose last Wednesday (i.e. 28Apr2021) and still the achy, the headache, the soreness but patient just like when this going to go away. Stated forehead was achy, achiness from the neck down to the feet, patient had a sore throat a coupe day ago, just basically patient can barely move, just fatigue. The outcome of all events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Narrative: Symptoms: UrticariaPruritus & itching to right face remains Treatment:
vaccination site pruritus; nasal congestion; sneezing; vaccination site swelling; A spontaneous report was received from a consumer concerning a 89- year old-female patient who received Modena's COVID-19 vaccine (mRNA-1273) and experienced injection site swelling and itching,nasal congestion and sneezing.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 15-feb-2021,prior to the onset of the events, the patient received their planned dose of mRNA-1273 (lot/batch 011M20A) intramuscularly  for prophylaxis of COVID-19 infection.   On 16-Feb-2021,she had an egg shaped swelling on the injection site which started to itch on day 4 post vaccination. this was associated with nasal congestion and sneezing. No laboratory data was provided.Treatment information was not provided.  Action taken with mRNA-1273 in response to the events  was unknown. The outcome of the events,injection site swelling,injection site itching,nasal congestion and sneezing was considered as unknown at the time of the report
Patient was inadvertently given 2mls of the 0.3ml recommended dose of this vaccine.  Only reactions that were reported by patient over 3 days post event were injection site soreness, fatigue, fever lasting less than 4-5 hours.
24 hours after vaccine, patient had a localized reaction (at site of vaccination) which progressed to erythematous, urticarial body wide rash. Rash progressively cleared and next 48 hours with residual macula-popular lower extremity exantm.
aches and pains; This is a spontaneous report from a contactable consumer (patient) received via a sales representative. A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced aches and pains on an unspecified date after the second dose of vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.